MedPath

Emotion-Cognition Interaction in Psychotic Disorders

Recruiting
Conditions
psychosis
Schizophrenia
10039628
Registration Number
NL-OMON33944
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
120
Inclusion Criteria

All patients with a diagnosis of *first episode psychosis* suggestive for the diagnosis schizophrenia are eligible to participate in the study. Age between 18 and 40 years. Patients may be inpatients or outpatients.
Appearance of first symptoms not longer than 3 years ago.

Exclusion Criteria

Any other psychiatric or neurological diseases.
Use of hard drugs as cocaine or heroin.
Alcohol addiction.
Subjects will also be excluded when they cannot understand the Dutch language sufficiently to understand the purposes and implications of the experiment.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>• To investigate the interaction between cognitive capacities and emotional<br /><br>capacities in schizophrenia.<br /><br>• To investigate whether patients with schizophrenia differ from healthy<br /><br>controls in their selective attention and the influence of an affective<br /><br>component on selective attention function.<br /><br>• To investigate whether patients with schizophrenia differ from healthy<br /><br>controls in their working memory and the influence of an affective component on<br /><br>working memory function.<br /><br>• To investigate whether patients with schizophrenia differ from healthy<br /><br>controls in their long-term visual memory and the influence of an affective<br /><br>component on long-term visual memory function.<br /><br>• To investigate whether patients with schizophrenia differ from healthy<br /><br>controls in their long-term verbal memory and the influence of an affective<br /><br>component on long-term verbal memory function.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>• To study whether there is an impact of pharmacological treatment and actual<br /><br>psychopathology on the interaction between cognitive capacities and emotional<br /><br>capacities in schizophrenia.</p><br>
© Copyright 2025. All Rights Reserved by MedPath